摘要 |
The present disclosure provides pyrimidine urea compounds useful in the treatment of p38 kinase mediated diseases, such as lymphoma and auto-inflammatory disease, having the structure of Formula (I): wherein R1, R3, R4, R5, V and W are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating p38 kinase mediated diseases using the compound. |
申请人 |
CONFLUENCE LIFE SCIENCES, INC.;SELNESS, SHAUN, R.;MONAHAN, JOSEPH, B.;SCHINDLER, JOHN, F.;DEVADAS, BALEKUDRU |
发明人 |
SELNESS, SHAUN, R.;MONAHAN, JOSEPH, B.;SCHINDLER, JOHN, F.;DEVADAS, BALEKUDRU |